A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 331 participants.

Also called NCT01614652

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 331 participants (enrolled count) (from the registry)
Sponsor
CardioKinetix, Inc (from the registry)
Registry
  • NCT NCT01614652
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01614652. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2017-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
Acronym
PARACHUTE IV
Condition
Congestive Heart Failure
Condition
Left Ventricular (LV) Systolic Dysfunction
Intervention (Device)
CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
Lead sponsor
CardioKinetix, Inc (class: industry)

Record details

Record id
cardio:ct-nct01614652
Content hash
1a0eda6f05b193c6416f752846d8bf4efc5ed763095d56a14bd8ece99597b214